Evidence of the importance of the first intracellular loop of prokineticin receptor 2 in receptor function

Molecular Endocrinology

Volumn 26, Issue 8, 2012, Pages 1417-1427

  Abreu, Ana Paula ^a,b   Noel, Sekoni D ^a   Xu, Shuyun ^a   Carroll, Rona S ^a   Latronico, Ana Claudia ^b   Kaiser, Ursula B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FIRST INTRACELLULAR LOOP; HUMAN; HUMAN CELL; HYPOGONADOTROPIC HYPOGONADISM; IN VITRO STUDY; LIGAND BINDING; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; WILD TYPE;

AMINO ACID MOTIFS; ANIMALS; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COS CELLS; GASTROINTESTINAL HORMONES; GENE EXPRESSION; GENES, DOMINANT; GLYCOSYLATION; HEK293 CELLS; HUMANS; HYPOGONADISM; INOSITOL PHOSPHATES; MUTATION, MISSENSE; NEUROPEPTIDES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION;

EID: 84864477056     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1102     Document Type: Article

References (57)

1. Ngan ES, Tam PK 2008 Prokineticin-signaling pathway. Int J Biochem Cell Biol 40:1679-1684
2. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY 2002 Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277:19276-19280
3. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K 2002 Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 1579:173-179
4. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y, Yamada T, Hinuma S, Inatomi N, Ohtaki T, Onda H, Fujino M 2002 Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 293:396-402
5. Chen J, Kuei C, Sutton S, Wilson S, Yu J, Kamme F, Mazur C, Lovenberg T, Liu C 2005 Identification and pharmacological characterization of prokineticin 2β as a selective ligand for prokineticin receptor 1. Mol Pharmacol 67:2070-2076
6. Lin R, LeCouter J, Kowalski J, Ferrara N 2002 Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 277: 8724-8729
7. Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J, Weaver DR, Leslie FM, Zhou QY 2002 Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417:405-410
8. Hu WP, Li JD, Zhang C, Boehmer L, Siegel JM, Zhou QY 2007 Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Sleep 30:247-256
9. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ, Ferrara N 2003 The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 100:2685-2690
10. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N 2004 Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 101:16813-16818
11. Li JD, Hu WP, Boehmer L, Cheng MY, Lee AG, Jilek A, Siegel JM, Zhou QY 2006 Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 26:11615-11623
12. Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY 2005 Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 308:1923-1927
13. Prosser HM, Bradley A, Chesham JE, Ebling FJ, Hastings MH, Maywood ES 2007 Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc Natl Acad Sci USA 104:648-653
14. Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A 2004 Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 64: 1906-1910
15. Monnier J, Piquet-Pellorce C, Feige JJ, Musso O, Clement B, Turlin B, Theret N, Samson M 2008 Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. World J Gastroenterol 14:1182-1191
16. Shojaei F, Wu X, Zhong C, Yu L, Liang XH, Yao J, Blanchard D, Bais C, Peale FV, van Bruggen N, Ho C, Ross J, Tan M, Carano RA, Meng YG, Ferrara N 2007 Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450:825-831
17. Cheng MY, Leslie FM, Zhou QY 2006 Expression of prokineticins and their receptors in the adult mouse brain. J Comp Neurol 498: 796-809
18. Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J, Kamohara M, Matsuo A, Ishii H, Kobori M, Katoh M, Matsushime H, Furuichi K, Shigeyoshi Y 2006 Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 103:4140-4145
19. Prosser HM, Bradley A, Caldwell MA 2007 Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur J Neurosci 26:3339-3344
20. Abreu AP, Trarbach EB, de Castro M, Frade Costa EM, Versiani B, Matias Baptista MT, Garmes HM, Mendonca BB, Latronico AC 2008 Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 93:4113-4118
21. Canto P, Munguía P, Söderlund D, Castro JJ, Méndez JP 2009 Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J Androl 30: 4145
22. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley Jr WF, Zhou QY, Pitteloud N 2008 Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 93:3551-3559
23. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP 2006 Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2:e175
24. Monnier C, Dodé C, Fabre L, Teixeira L, Labesse G, Pin JP, Hardelin JP, Rondard P 2009 PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Hum Mol Genet 18:75-81
25. Sinisi AA, Asci R, Bellastella G, Maione L, Esposito D, Elefante A, De Bellis A, Bellastella A, Iolascon A 2008 Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum Reprod 23:2380-2384
26. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, Seminara SB, Crowley Jr WF, Pitteloud N 2010 Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 107:15140-15144
27. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Piñero A, Wolczynski S, Brailly-Tabard S, Bidet M, Ramos-Arroyo M, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dodé C, Young J 2010 A comparative phenotypic study of Kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab 95:659-669
28. Abreu AP, Kaiser UB, Latronico AC 2010 The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism. Neuroendocrinology 91:283-290
29. Oldham WM, Hamm HE 2008 Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9:60-71
30. Wess J 1997 G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11:346-354
31. Conn PM, Janovick JA 2009 Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease. Mol Cell Endocrinol 299:137-145
32. Conn PM, Ulloa-Aguirre A, Ito J, Janovick JA 2007 G proteincoupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev 59: 225-250
33. Duvernay MT, Dong C, Zhang X, Zhou F, Nichols CD, Wu G 2009 Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum. Mol Pharmacol 75:751-761
34. Wess J 1998 Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 80:231-264
35. Kleinau G, Jaeschke H, Worth CL, Mueller S, Gonzalez J, Paschke R, Krause G 2010 Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor. PLoS One 5:e9745
36. Wu V, Yang M, McRoberts JA, Ren J, Seensalu R, Zeng N, Dagrag M, Birnbaumer M, Walsh JH 1997 First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem 272:9037-9042
37. Arora KK, Krsmanovic LZ, Mores N, O'Farrell H, Catt KJ 1998 Mediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptor. J Biol Chem 273: 25581-25586
38. Duvernay MT, Dong C, Zhang X, Robitaille M, Hébert TE, Wu G 2009 A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors. Traffic 10:552-566
39. Schwachtgen JL, Houston P, Campbell C, Sukhatme V, Braddock M 1998 Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. J Clin Invest 101:2540-2549
40. Bedecarrats GY, Linher KD, Kaiser UB 2003 Two common naturally occurring mutations in the human gonadotropin-releasing hormone (GnRH) receptor have differential effects on gonadotropin gene expression and on GnRH-mediated signal transduction. J Clin Endocrinol Metab 88:834-843
41. Maley F, Trimble RB, Tarentino AL, Plummer Jr TH 1989 Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 180:195-204
42. Marsango S, Bonaccorsi di Patti MC, Barra D, Miele R 2011 Evidence that prokineticin receptor 2 exists as a dimer in vivo. Cell Mol Life Sci 68:2919-2929
43. Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, Kaiser UB, Seminara SB, Pitteloud N, Zhou QY, Crowley Jr WF 2011 The role of the Prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations. Endocr Rev 32:225-246
44. Ruiz-Ferrer M, Torroglosa A, Núñez-Torres R, de Agustín JC, Antiñolo G, Borrego S 2011 Expression of PROKR1 and PROKR2 in human enteric neural precursor cells and identification of sequence variants suggest a role in HSCR. PLoS One 6:e23475
45. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V, Elting MW, Padidela R, Plummer L, Martin C, Feng B, Zhang C, Zhou QY, Chen H, Mohammadi M, Quinton R, Sidis Y, Radovick S, Dattani MT, Pitteloud N 2012 Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 97:E694-E699
46. Peng Z, Tang Y, Luo H, Jiang F, Yang J, Sun L, Li JD 2011 Diseasecausing mutation in PKR2 reveals a critical role of positive charges in the second intracellular loop for G-protein coupling and receptor trafficking. J Biol Chem 286:16615-16622
47. Clouser CL, Menon KM 2005 N-linked glycosylation facilitates processing and cell surface expression of rat luteinizing hormone receptor. Mol Cell Endocrinol 235:11-19
48. Roy S, Perron B, Gallo-Payet N 2010 Role of asparagine-linked glycosylation in cell surface expression and function of the human adrenocorticotropin receptor (melanocortin 2 receptor) in 293/ FRT cells. Endocrinology 151:660-670
49. Kelley LP, Kinsella BT 2003 The role of N-linked glycosylation in determining the surface expression, G protein interaction and effector coupling of the alpha () isoform of the human thromboxane A(2) receptor. Biochim Biophys Acta 1621:192-203
50. van Koppen CJ, Nathanson NM 1990 Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor. Analysis of the role of N-glycosylation in receptor expression and function. J Biol Chem 265:20887-20892
51. Davidson JS, Flanagan CA, Zhou W, Becker II, Elario R, Emeran W, Sealfon SC, Millar RP 1995 Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding. Mol Cell Endocrinol 107: 241-245
52. Hamilton SR, Gerngross TU 2007 Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr Opin Biotechnol 18:387-392
53. Hart GW, Brew K, Grant GA, Bradshaw RA, Lennarz WJ 1979 Primary structural requirements for the enzymatic formation of the N-glycosidic bond in glycoproteins. Studies with natural and synthetic peptides. J Biol Chem 254:9747-9753
54. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley Jr WF, Martin KA, Hall JE, Pitteloud N 2011 A genetic basis for functional hypothalamic amenorrhea. N Engl J Med 364:215-225
55. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, Bibikova M, Chudin E, Barker DL, Dickinson T, Fan JB, Hudson TJ 2008 Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 4:e1000006
56. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M, Crowley W 2007 Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117:457-463
57. Balasubramanian R, Plummer L, Sidis Y, Pitteloud N, Martin C, Zhou QY, Crowley Jr WF 2011 The puzzles of the prokineticin 2 pathway in human reproduction. Mol Cell Endocrinol 346:44-50